deferoxamine has been researched along with Siderosis in 81 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Siderosis: A form of pneumoconiosis resulting from inhalation of iron in the mining dust or welding fumes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiac events and death are not uncommon in adults with beta-thalassemia (b-TM) taking deferoxamine (DFO) monotherapy because of poor compliance and possibly the less effectiveness of DFO in controlling cardiac iron overload." | 7.76 | Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine. ( Abdin, IA; Ebeid, FS; El Safy, UR; Elalfy, MS; Ibrahim, AS; Salem, DS, 2010) |
| "Deferiprone monotherapy was significantly more effective than deferoxamine over 1 year in improving asymptomatic myocardial siderosis in beta-thalassemia major." | 6.72 | Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. ( Aessopos, A; Berdoukas, V; Galanello, R; Gotsis, ED; Karagiorga, M; Ladis, V; Pennell, DJ; Piga, A; Smith, GC; Tanner, MA; Westwood, MA; Wonke, B, 2006) |
| "In patients with severe myocardial siderosis and impaired LV function, combined chelation therapy with subcutaneous deferoxamine and oral deferiprone reduces myocardial iron and improves cardiac function." | 5.13 | Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. ( Agus, A; Dessi, C; Galanello, R; Nair, SV; Pennell, DJ; Pibiri, M; Smith, GC; Tanner, MA; Walker, JM; Westwood, MA, 2008) |
| "Cardiac events and death are not uncommon in adults with beta-thalassemia (b-TM) taking deferoxamine (DFO) monotherapy because of poor compliance and possibly the less effectiveness of DFO in controlling cardiac iron overload." | 3.76 | Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine. ( Abdin, IA; Ebeid, FS; El Safy, UR; Elalfy, MS; Ibrahim, AS; Salem, DS, 2010) |
| "Deferiprone monotherapy was significantly more effective than deferoxamine over 1 year in improving asymptomatic myocardial siderosis in beta-thalassemia major." | 2.72 | Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. ( Aessopos, A; Berdoukas, V; Galanello, R; Gotsis, ED; Karagiorga, M; Ladis, V; Pennell, DJ; Piga, A; Smith, GC; Tanner, MA; Westwood, MA; Wonke, B, 2006) |
| "In transfusion-dependent ss-thalassemia major, increased iron deposition in the pituitary gland has a cytotoxic effect, leading mainly to hypogonadotropic hypogonadism." | 1.31 | T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. ( Argyropoulou, MI; Bitsis, S; Efremidis, S; Kiortsis, DN; Metafratzi, Z; Tsatsoulis, A, 2000) |
| "A 32 year old woman with severe aplastic anaemia required frequent transfusions and consequently developed hyperferrioxaemia (54 microMol/l) and hyperferritinaemia (1,700 ng/ml)." | 1.27 | High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis. ( Bleyl, H; Breithaupt, H; Graef, V; Guttmann, W; Heckers, H; Jundt, G; Pralle, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 72 (88.89) | 18.7374 |
| 1990's | 3 (3.70) | 18.2507 |
| 2000's | 5 (6.17) | 29.6817 |
| 2010's | 1 (1.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, CT | 1 |
| Chang, JS | 1 |
| Wang, LY | 1 |
| Chiou, SS | 1 |
| Hsiao, CC | 1 |
| Wang, SC | 1 |
| Hung, GY | 1 |
| Wu, KH | 1 |
| Elalfy, MS | 1 |
| Abdin, IA | 1 |
| El Safy, UR | 1 |
| Ibrahim, AS | 1 |
| Ebeid, FS | 1 |
| Salem, DS | 1 |
| ALBAHARY, C | 3 |
| RENAULT, J | 1 |
| LABARBE, P | 1 |
| GIRAUD, J | 1 |
| NORMAN, CS | 1 |
| REWALD, E | 1 |
| SCURO, LA | 5 |
| BROCCIA, G | 1 |
| DOBRILLA, G | 5 |
| TAGLIAMONTE, A | 1 |
| CARVALHONETO, E | 1 |
| CHAVANNE, H | 1 |
| DEMILLIERE, B | 1 |
| TURA, S | 1 |
| RICCI-BITTI, ML | 1 |
| LODI, L | 1 |
| RISSEL, E | 1 |
| Pennell, DJ | 2 |
| Berdoukas, V | 1 |
| Karagiorga, M | 1 |
| Ladis, V | 1 |
| Piga, A | 1 |
| Aessopos, A | 1 |
| Gotsis, ED | 1 |
| Tanner, MA | 2 |
| Smith, GC | 2 |
| Westwood, MA | 2 |
| Wonke, B | 1 |
| Galanello, R | 2 |
| Hershko, C | 2 |
| Dessi, C | 1 |
| Agus, A | 1 |
| Pibiri, M | 1 |
| Nair, SV | 1 |
| Walker, JM | 1 |
| Valvo, A | 2 |
| Walsh, JR | 2 |
| Mass, RE | 1 |
| Williams, R | 1 |
| Lechi, A | 1 |
| Innecco, A | 1 |
| Cavallini, G | 1 |
| Green, R | 1 |
| Lamon, J | 1 |
| Curran, D | 1 |
| Jacobs, A | 1 |
| Ting, WC | 1 |
| Piomelli, S | 1 |
| Graziano, J | 1 |
| Choi, YC | 1 |
| Hough, AJ | 1 |
| Morris, GM | 1 |
| Sokoloff, L | 1 |
| Ceriati, F | 1 |
| Pomponi, M | 1 |
| Cavicchioni, C | 1 |
| Marino, IR | 1 |
| Carelli, G | 1 |
| Cremona, G | 1 |
| Declercq, SS | 1 |
| Krawczuk-Hermanowicz, O | 1 |
| Smolińska, K | 1 |
| Richardson, ME | 1 |
| Matthews, RN | 1 |
| Alison, JF | 1 |
| Menahem, S | 1 |
| Mitvalsky, J | 1 |
| Byrt, E | 1 |
| Harper, RW | 1 |
| Lange, B | 1 |
| Hofweber, K | 1 |
| Waldherr, R | 1 |
| Schärer, K | 1 |
| Link, G | 1 |
| Cabantchik, I | 1 |
| Argyropoulou, MI | 1 |
| Metafratzi, Z | 1 |
| Kiortsis, DN | 1 |
| Bitsis, S | 1 |
| Tsatsoulis, A | 1 |
| Efremidis, S | 1 |
| Barcellona, R | 2 |
| Masseria, R | 2 |
| Palmigiano, C | 2 |
| Amato, GM | 2 |
| Kramer, P | 1 |
| Arnold, H | 1 |
| Wehinger, H | 1 |
| Deus, B | 1 |
| Löhr, GW | 1 |
| Nienhuis, AW | 2 |
| Strohmeyer, G | 1 |
| Propper, RD | 1 |
| Cooper, B | 1 |
| Rufo, RR | 1 |
| Anderson, WF | 1 |
| Bunn, HF | 1 |
| Rosenthal, A | 1 |
| Nathan, DG | 1 |
| Kautzsch, E | 1 |
| Risdon, RA | 1 |
| Barry, M | 2 |
| Flynn, DM | 1 |
| Peyresblanques, MJ | 1 |
| Robins-Browne, RM | 1 |
| Prpic, JK | 1 |
| Stuart, SJ | 1 |
| Gelmi, C | 1 |
| Borgna-Pignatti, C | 1 |
| Franchin, S | 1 |
| Tacchini, M | 1 |
| Trimarchi, F | 1 |
| Gerkowicz, K | 2 |
| Prost, M | 2 |
| Breithaupt, H | 1 |
| Heckers, H | 1 |
| Pralle, H | 1 |
| Guttmann, W | 1 |
| Bleyl, H | 1 |
| Graef, V | 1 |
| Jundt, G | 1 |
| Bobeck-Rutsaert, MM | 1 |
| op den Kelder, AM | 1 |
| Wiltink, WF | 1 |
| van Eijk, HG | 1 |
| Leijnse, B | 1 |
| Stich, W | 1 |
| Turbina, NS | 2 |
| Khutsishvili, GE | 1 |
| Soboleva, IuG | 1 |
| Stacher, A | 1 |
| Turnbull, A | 1 |
| Michaelis, D | 1 |
| Takác, A | 1 |
| Bruns, W | 1 |
| Asenjo, A | 1 |
| Rojas, G | 1 |
| Aranda, L | 1 |
| Weinstein, V | 1 |
| Oberhauser, E | 1 |
| Wöhler, F | 1 |
| Fiaschi, E | 1 |
| Bianco, G | 1 |
| Gallo, E | 1 |
| Ramello, A | 1 |
| Ricco, G | 1 |
| Matone, S | 1 |
| Wapnick, AA | 1 |
| Lynch, SR | 1 |
| Charlton, RW | 1 |
| Seftel, HC | 1 |
| Bothwell, TH | 1 |
| Cartei, G | 1 |
| Sherlock, S | 1 |
| Campana, G | 1 |
| Boschi, MC | 1 |
| Lobitz, WC | 1 |
| Mahler, DJ | 1 |
| Kingery, FA | 1 |
| Fielding, J | 1 |
| Duverne, J | 1 |
| Brizard, CP | 1 |
| Mounier, R | 1 |
| Pecora, L | 1 |
| Cascini, F | 1 |
| De Siena, F | 1 |
| Bessière, E | 1 |
| Verin, P | 1 |
| Le Rebeller, MJ | 1 |
| Descamp, F | 1 |
| Beurey, J | 1 |
| Weber, M | 1 |
| Gurecki, H | 1 |
| Perello, R | 1 |
| Vadot, J | 1 |
| Luongo, E | 1 |
| el-Gholmy, A | 1 |
| Khalifa, AS | 1 |
| Rahman, YA | 1 |
| el-Bagoury, I | 1 |
| Lange, J | 1 |
| Orsini, A | 1 |
| Giraud, F | 1 |
| Bernard, P | 1 |
| Passeron, P | 1 |
| Del Duca, A | 1 |
| Scandellari, C | 1 |
| Plachecka-Gutowska, M | 1 |
| Mikolajew, M | 1 |
| McEnery, JT | 1 |
| Greengard, J | 1 |
| Wise, JB | 1 |
| Falbe-Hansen, I | 1 |
| Aron, E | 2 |
| Weill, JD | 2 |
| Jobard, P | 1 |
| Galand, A | 2 |
| Domenech, J | 1 |
| Paufique, L | 1 |
| Bonnet, M | 1 |
| Didierlaurent, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance[NCT00103753] | Phase 4 | 65 participants | Interventional | 2004-05-31 | Active, not recruiting | ||
| The Effect of Treatment With the Oral Iron Chelator Deferiprone on the Oxidative Stress of Blood Cells and on Iron Overload Status in Transfusion Dependent, Iron-overloaded Patients With Low Risk Myelodysplastic Syndrome[NCT02477631] | Phase 2 | 19 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for deferoxamine and Siderosis
| Article | Year |
|---|---|
Pathophysiology of iron overload.
Topics: Animals; Cardiomyopathies; Deferoxamine; Free Radicals; Humans; Iron; Siderosis; Thalassemia; Transf | 1998 |
Yersiniae and iron. A study in host-parasite relationships.
Topics: Deferoxamine; Humans; Iron; Siderosis; Virulence; Yersinia; Yersinia Infections | 1987 |
[Use of desferal in treatment of sideroses of different origin. (Literature review)].
Topics: Anemia; Anemia, Aplastic; Anemia, Sideroblastic; Animals; Bile; Child, Preschool; Deferoxamine; Hemo | 1968 |
[Diseases caused by iron metabolism disorders and their therapy].
Topics: Adult; Anemia, Hypochromic; Anti-Glomerular Basement Membrane Disease; Bloodletting; Deferoxamine; D | 1969 |
Iron metabolism in the porphyrias.
Topics: Alcohol Drinking; Amino Acids; Anemia, Hemolytic; Bloodletting; Bone Marrow; Bone Marrow Diseases; D | 1971 |
[Recent findings on the subject of diagnosis of hypersiderosis].
Topics: Deferoxamine; Humans; Iron; Siderosis | 1967 |
3 trials available for deferoxamine and Siderosis
| Article | Year |
|---|---|
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.
Topics: Adult; beta-Thalassemia; Cardiomyopathies; Deferiprone; Deferoxamine; Female; Humans; Iron; Iron Che | 2006 |
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.
Topics: Administration, Oral; Adult; beta-Thalassemia; Cardiomyopathies; Deferiprone; Deferoxamine; Drug The | 2008 |
Clinical trial of desferrioxamine entrapped in red cell ghosts.
Topics: Adult; Aged; Anemia; Anemia, Aplastic; Blood Transfusion; Clinical Trials as Topic; Deferoxamine; Er | 1980 |
72 other studies available for deferoxamine and Siderosis
| Article | Year |
|---|---|
Update on thalassemia treatment in Taiwan, including bone marrow transplantation, chelation therapy, and cardiomyopathy treatment effects.
Topics: Benzoates; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Cardiomyopathies; Chela | 2009 |
Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine.
Topics: Adolescent; Age Factors; Benzoates; beta-Thalassemia; Child; Child, Preschool; Death; Deferasirox; D | 2010 |
[The treatment of siderosis by desferrioxamine B. Comparison with the action of 2 other chelating agents].
Topics: Chelating Agents; Deferoxamine; Edetic Acid; Humans; Siderosis | 1962 |
THE TREATMENT OF IRON OVERLOAD WITH DESFERRIOXAMINE B.
Topics: Anemia; Anemia, Aplastic; Blood Transfusion; Deferoxamine; Humans; Hydroxamic Acids; Iron Chelating | 1964 |
SUBSTITUTIVE-INHIBITORY THERAPY IN CONSTITUTIONAL NON-SPHEROCYTIC ERYTHROCYTIC DISEASE.
Topics: Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital Nonspherocytic; Blood Transfusion; Deferoxa | 1964 |
[A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
Topics: Anemia; Anemia, Hypochromic; Biomedical Research; Deferoxamine; Hematologic Diseases; Hemochromatosi | 1964 |
[DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
Topics: Anemia; Anemia, Hypochromic; Blood Transfusion; Calcium; Chelating Agents; Deferoxamine; Drug Therap | 1965 |
[SOMETHING NEW FOR THE TREATMENT OF SIDEROSIS].
Topics: Deferoxamine; Hemochromatosis; Humans; Siderosis | 1964 |
[TRIAL OF A NEW IRON CHELATOR, DESFERRIOXAMINE B, IN A CASE OF OCULAR SIDEROSIS].
Topics: Chelating Agents; Deferoxamine; Eye Diseases; Heavy Metal Poisoning; Humans; Iron; Iron Metabolism D | 1964 |
[USE OF DESFERRIOXAMINE B IN DIAGNOSIS AND THERAPY OF HYPERSIDEROSIS].
Topics: Deferoxamine; Humans; Siderosis | 1964 |
[ON THE TREATMENT OF HEPATIC SIDEROSIS].
Topics: Deferoxamine; Drug Therapy; Hemochromatosis; Hepatolenticular Degeneration; Humans; Liver Diseases; | 1964 |
Oral iron chelators: new opportunities and new dilemmas.
Topics: Administration, Oral; Animals; Deferoxamine; Humans; Iron Chelating Agents; Iron Overload; Siderosis | 2006 |
Desferrioxamine B in ophthalmology. Applications and therapeutic possibilities.
Topics: Adult; Animals; Cornea; Deferoxamine; Eye Diseases; Eye Foreign Bodies; Humans; Male; Rabbits; Sider | 1967 |
Hypersiderosis.
Topics: Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Iron; Siderosis | 1967 |
Cirrhosis with secondary siderosis or primary haemochromatosis.
Topics: Alcoholism; Deferoxamine; Diagnosis, Differential; Hemochromatosis; Humans; Iron; Iron Isotopes; Liv | 1967 |
Twenty-four hour desferrioxamine test in normal, iron deficient and hypersideraemic (both hypersiderotic and non-hypersiderotic) subjects.
Topics: Adult; Deferoxamine; Deficiency Diseases; Hepatitis A; Humans; Iron; Middle Aged; Siderosis | 1967 |
Siderosis, haemolysis or hepatonecrosis in increasing post-desferrioxamine sideruria in acute viral hepatitis?
Topics: Deferoxamine; Hemolysis; Hepatitis A; Humans; Iron; Liver Diseases; Necrosis; Siderosis | 1967 |
Iron chelation with oral desferrioxamine.
Topics: Deferoxamine; Humans; Siderosis; Transfusion Reaction | 1980 |
Reduction of iron overload in thalassemia.
Topics: Adolescent; Adult; Aging; Animals; Cell Separation; Child; Child, Preschool; Deferoxamine; Erythrocy | 1982 |
Experimental siderosis of articular chondrocytes cultured in vitro.
Topics: Animals; Ascorbic Acid; Cartilage, Articular; Cattle; Cells, Cultured; Deferoxamine; Disease Models, | 1981 |
Continuous intra-venous (CIV) infusion of desferrioxamine (DF) in a hemodialysed patient with transfusion siderosis.
Topics: Adult; Deferoxamine; Humans; Infusions, Parenteral; Male; Renal Dialysis; Siderosis; Transfusion Rea | 1981 |
Desferrioxamine in ocular siderosis: a long-term electrophysiological evaluation.
Topics: Animals; Deferoxamine; Electroretinography; Eye Diseases; Eye Foreign Bodies; Rabbits; Siderosis | 1980 |
[Clinical aspects of ocular siderosis].
Topics: Adult; Deferoxamine; Eye Diseases; Eye Foreign Bodies; Humans; Hydroxamic Acids; Iron; Male; Sideros | 1980 |
Prevention of heart disease by subcutaneous desferrioxamine in patients with thalassaemia major.
Topics: Adolescent; Adult; beta-Thalassemia; Cardiomyopathies; Child; Deferoxamine; Electrocardiography; Fem | 1993 |
Congenital erythropoietic porphyria associated with nephrotic syndrome and renal siderosis.
Topics: Anti-Inflammatory Agents; Child; Deferoxamine; Glomerular Filtration Rate; Humans; Iron Chelating Ag | 1995 |
T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major.
Topics: Adult; beta-Thalassemia; Case-Control Studies; Chelating Agents; Deferoxamine; Female; Ferritins; Hu | 2000 |
[Experience with desferrioxamine treatment by slow subcutaneous administration, in thalassemia].
Topics: Adolescent; Adult; Child; Deferoxamine; Female; Humans; Injections, Intramuscular; Male; Siderosis; | 1979 |
[Experience with desferrioxamine treatment by intravenous administration, in thalassemia].
Topics: Child; Deferoxamine; Female; Humans; Infusions, Parenteral; Male; Siderosis; Thalassemia; Transfusio | 1979 |
Intravenous or subcutaneous deferoxamine for iron overload?
Topics: Deferoxamine; Humans; Infusions, Parenteral; Injections, Subcutaneous; Siderosis | 1978 |
[Controlled desferrioxamine treatment of congenital anaemia and transfusion siderosis (author's transl)].
Topics: Adolescent; Anemia, Aplastic; Child; Deferoxamine; Erythrocytes, Abnormal; Humans; Iron; Male; Sider | 1978 |
Safety of intensive chelation therapy.
Topics: Adolescent; Adult; Ascorbic Acid; Deferoxamine; Drug Synergism; Humans; Siderosis | 1977 |
[Iron storage disease].
Topics: Deferoxamine; Diagnosis, Differential; Hemochromatosis; Humans; Siderosis | 1977 |
Continuous subcutaneous administration of deferoxamine in patients with iron overload.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ascorbic Acid; Child; Child, Preschool; Deferoxamine; | 1977 |
[Letter: Therapy of hemochromatosis].
Topics: Bloodletting; Deferoxamine; Hemochromatosis; Humans; Porphyrias; Siderosis | 1975 |
Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia.
Topics: Adolescent; Adult; Age Factors; Biopsy; Child; Child, Preschool; Deferoxamine; Humans; Iron; Iron Ch | 1975 |
[Adapto-electroretinography (AERG); siderosis due to intraocular foreign body, and Desferal].
Topics: Adult; Deferoxamine; Electroretinography; Eye Foreign Bodies; Humans; Male; Siderosis | 1975 |
Electroretinographic and visual-evoked potential abnormalities in patients with beta-thalassemia major.
Topics: Adolescent; Adult; Child; Deferoxamine; Electroretinography; Evoked Potentials, Visual; Eye; Humans; | 1988 |
[Therapeutical procedures for iron foreign bodies in the orbit].
Topics: Animals; Deferoxamine; Eye; Eye Foreign Bodies; Iron; Orbit; Rabbits; Siderosis | 1987 |
High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.
Topics: Adult; Anemia, Aplastic; Bone Marrow; Deferoxamine; Feces; Female; Ferritins; Humans; Iron; Siderosi | 1986 |
Studies on the use of desferrioxamine in experimental ocular siderosis produced by extrabulbar administration of iron.
Topics: Animals; Deferoxamine; Eye; Eye Diseases; Eye Foreign Bodies; Iron; Rabbits; Siderosis | 1985 |
Site of action of desferrioxamine in removing iron in normal and pathological conditions.
Topics: Anemia; Animals; Brain Chemistry; Deferoxamine; Heart; Infusions, Parenteral; Iron; Iron-Dextran Com | 1974 |
[Diagnosis and therapy of iron-deficiency and sideroachrestic anemias].
Topics: Anemia, Hypochromic; Anemia, Macrocytic; Bloodletting; Deferoxamine; Hemochromatosis; Humans; Iron; | 1973 |
[Effectiveness of Desferal in diseases occurring simultaneously with hypersiderosis].
Topics: Adult; Anemia, Aplastic; Deferoxamine; Humans; Middle Aged; Siderosis | 1973 |
[The diagnostic value of the desferrioxamine B test in the latent form of primary idiopathic hemochromatosis].
Topics: Adolescent; Adult; Child; Deferoxamine; Edetic Acid; Female; Hemochromatosis; Humans; Iron; Male; Mi | 1966 |
[Cytosiderosis and deposits of iron in the ventrolateral nucleus of the thalamus in Parkinson's disease. Clinical and experimental study].
Topics: Animals; Cerebral Cortex; Cytoplasmic Granules; Deferoxamine; Electromyography; Ferritins; Haplorhin | 1969 |
Diagnosis of iron storage disease with desferrioxamine (Desferal test).
Topics: Anemia, Macrocytic; Anemia, Sickle Cell; Deferoxamine; Female; Hemochromatosis; Hemosiderosis; Human | 1964 |
[Therapy of primary siderochromatosis and siderosis: experimental and clinical study].
Topics: Bloodletting; Deferoxamine; Hemochromatosis; Humans; Intestinal Absorption; Iron; Porphyrias; Primar | 1969 |
The effect of ascorbic acid deficiency on desferrioxamine-induced urinary iron excretion.
Topics: Ascorbic Acid; Ascorbic Acid Deficiency; Deferoxamine; Hemochromatosis; Humans; Iron; Leukocytes; Ma | 1969 |
Differential ferrioxamine test in haemochromatosis and liver diseases.
Topics: Adult; Bloodletting; Cholestasis; Deferoxamine; Diagnosis, Differential; Female; Hemochromatosis; Hu | 1969 |
[Clinical and experimental results of the treatment of some ocular diseases with desferrioxamine B].
Topics: Adolescent; Adult; Animals; Cornea; Deferoxamine; Eye Diseases; Eye Foreign Bodies; Hemorrhage; Huma | 1969 |
Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals.
Topics: Aged; Bloodletting; Copper; Deferoxamine; Hematopoiesis; Humans; Iron; Liver Function Tests; Magnesi | 1970 |
Storage iron and desferrioxamine.
Topics: Adolescent; Adult; Age Factors; Aged; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Macrocytic; De | 1970 |
[Inveterate leg ulcer in a constitutional hemolytic syndrome with dermosiderosis. Cure by desfrrioxamine].
Topics: Adult; Deferoxamine; Humans; Leg Ulcer; Male; Siderosis; Skin Diseases; Thalassemia | 1967 |
[Research on the desferrioxamine test in welders].
Topics: Adult; Deferoxamine; Humans; Iron; Lung Diseases; Middle Aged; Occupational Diseases; Siderosis; Wel | 1967 |
[Case of ocular siderosis ameliorated by deferoxamine].
Topics: Deferoxamine; Electroretinography; Eye Diseases; Humans; Male; Middle Aged; Siderosis | 1967 |
[Favorable clinical and biological action of iron chelator in 4 cases of porphyria cutanea tarda. Attempts at interpretation].
Topics: Adult; Aged; Alcoholism; Deferoxamine; Humans; Male; Porphyrias; Siderosis; Skin Diseases | 1968 |
[Treatment of ocular siderosis with desferrioxamine B].
Topics: Adolescent; Adult; Deferoxamine; Eye Diseases; Eye Foreign Bodies; Eye Injuries; Humans; Male; Sider | 1968 |
Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
Topics: Child; Child, Preschool; Deferoxamine; Female; Hemosiderosis; Humans; Iron; Liver; Male; Siderosis; | 1969 |
[Chemica damage to the eye in industrial medicine].
Topics: Argyria; Burns, Chemical; Caustics; Chelating Agents; Chronic Disease; Copper; Deferoxamine; Dimerca | 1969 |
[The desferrioxamine test in diagnosis of siderosis].
Topics: Deferoxamine; Humans; Siderosis | 1965 |
[Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis].
Topics: Adolescent; Anemia, Hemolytic; Child; Child, Preschool; Deferoxamine; Female; Humans; Male; Siderosi | 1965 |
[Applications of a new chelating substance in ophthalmology. Therapeutic results in a case of ocular siderosis treated with desferrioxamine B].
Topics: Adult; Deferoxamine; Eye Diseases; Eye Foreign Bodies; Female; Humans; Siderosis | 1965 |
[The treatment of siderosis: elective activity of desferrioxamine B].
Topics: Deferoxamine; Humans; Siderosis | 1963 |
[Observations on the behavior of iron in the human organism after administration of desferrioxamine].
Topics: Deferoxamine; Female; Humans; In Vitro Techniques; Iron; Male; Siderosis | 1965 |
[Recent progress in diagnosis of siderosis: the desferrioxamine test].
Topics: Deferoxamine; Humans; Siderosis | 1965 |
[Specific treatment of excessive iron deposition in the tissues].
Topics: Administration, Oral; Bloodletting; Chelating Agents; Connective Tissue; Deferoxamine; Hemochromatos | 1965 |
Treatment of acute iron ingestion with deferoxamine in 20 children.
Topics: Child, Preschool; Deferoxamine; Humans; Infant; Siderosis | 1966 |
Treatment of experimental siderosis bulbi, vitreous hemorrhage, and corneal blood staining with deferoxamine.
Topics: Animals; Blood Stains; Cornea; Deferoxamine; Eye Diseases; Hemorrhage; In Vitro Techniques; Rabbits; | 1966 |
Treatment of ocular siderosis and haemochromatosis with desferrioxamine.
Topics: Deferoxamine; Eye Diseases; Eye Foreign Bodies; Eye Injuries; Hemorrhage; Humans; Injections, Intram | 1966 |
[Respective variations of sideremia and sideruria in cirrhotic patients following the desferrioxamine B test].
Topics: Deferoxamine; Hemosiderosis; Humans; Iron; Liver Cirrhosis; Siderosis | 1966 |
[Our experience with desferrioxamine B in the treatment of ocular siderosis (apropos of 6 cases)].
Topics: Adult; Deferoxamine; Eye Foreign Bodies; Humans; Male; Middle Aged; Siderosis | 1966 |
[Respective variations of iron in blood and urine in cirrhotic and alcoholic patients after a desferrioxamine test].
Topics: Alcoholism; Deferoxamine; Diagnosis, Differential; Female; Hemochromatosis; Humans; Iron; Liver Cirr | 1966 |